Cargando…
Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention
Effective platelet inhibition is the main goal of the antiplatelet therapy recommended as a standard treatment in the secondary prevention of non-embolic ischemic stroke. Acetylsalicylic acid (aspirin) and clopidogrel are commonly used for this purpose worldwide. A low biological response to antipla...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827369/ https://www.ncbi.nlm.nih.gov/pubmed/33435185 http://dx.doi.org/10.3390/medicina57010059 |